A Win For BELLUS Health Inc.
BELLUS Health Inc. (BLU:NASDAQ) rocketted at $8.3, a gain of 48.2%. The stock got featured on our News Catalysts scanner on Mon, Dec 13, 2021 at 04:48 PM in the 'PUBLIC OFFERING' category. From Fri, Nov 26, 2021, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Nov 01, 2021 at $7.65 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About BELLUS Health Inc. (BLU:NASDAQ)
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, development of drug candidates for health solutions.
Top 10 Gainers:
- SeaChange International, Inc. (SEAC:NASDAQ), 128.81%
- Arena Pharmaceuticals, Inc. (ARNA:NASDAQ), 80.38%
- FHTX (FHTX:NASDAQ), 54.96%
- BELLUS Health Inc. (BLU:NASDAQ), 48.21%
- PTPI (PTPI:NASDAQ), 47.41%
- Energy Focus, Inc. (EFOI:NASDAQ), 36.23%
- East Stone Acquisition Corporation (ESSC:NASDAQ), 31.43%
- Nuverra Environmental Solutions, Inc. (NES:NYSEMKT), 30.22%
- Puxin Limited (NEW:NYSE), 27.13%
- BFRI (BFRI:NASDAQ), 27%